Project Grant R03OD039982
Award Date
6/10/25
Completion Date
5/31/26
Dollars Obligated
$312K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will provide $406,250.00 to The Trustees of the University of Pennsylvania over a period of approximately 5 years, from June 2025 to April 2030. The award will support research aimed at mechanistically understanding how circadian and metabolic rhythms shape the maturation and maintenance of fully differentiated cells. Key objectives...
This federal Project Grant award of $1,457,999.00 from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) supports research on how the circadian clock coordinates animal and microbial metabolism. The funded project aims to investigate the mechanisms by which circadian clocks and feeding rhythms promote oscillations in microbiome composition and function, and how these microbial metabolic cycles impact host physiology. The...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $483,077 to Baylor College of Medicine to investigate the role of the noncanonical clock transcription factor ESRRG in regulating circadian enhancer-promoter interactions during the progression from nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). The key objectives are to define how ESRRG rhythmicity affects NAFLD-to-HCC progression, determine how...
This $574,021 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to investigate the molecular mechanisms connecting circadian rhythms and lipid metabolism. The 5-year project led by the University of Missouri System will use a range of techniques, including lipid imaging, subcellular lipidomics, and genetic editing, to address three key knowledge gaps: 1) how the lipid messenger phosphatidic...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $616,495 to The University of Texas M.D. Anderson Cancer Center to investigate the role of sulfatide metabolism in pancreatic cancer precursor lesions. The key objectives are to: Define the biological functions of sulfatides in the development and progression of pancreatic cancer precursor lesions, such as intraductal papillary mucinous neoplasm (IPMN). This will involve using...
This Project Grant award, titled "A NOVEL IMMUNOTHERAPY FOR PANCREATIC CANCER USING MICRO-RNA-29A," was provided by the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) to the University of Miami in the amount of $107,948. The award will support research to determine the contribution of the TNFR2-miR-29a axis to CD8 T cell dysfunction in pancreatic ductal adenocarcinoma (PDAC), with the goal of generating durable T-cell mediated anti-tumor activity. The...
The University of California, San Francisco (UCSF) has been awarded a $1,453,500 Project Grant under the National Institutes of Health (NIH) Trans-NIH Research Support (CFDA 93.310) program. The grant, awarded on September 20, 2023 with a completion date of August 31, 2026, will support UCSF's research to decipher the fundamental principles of autonomous cellular clocks and uncover their role in regulating critical cellular processes like metabolism, organelle biogenesis, and mitotic fidelity....
This Project Grant award, with a total funding amount of $848,914, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research focused on understanding the impact of HIV co-infections and comorbidities on circadian rhythm in the liver. The research aims to investigate how disruption of circadian clock genes, pathways, and functions may...
This Project Grant award for $536,186.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct research on APOBEC3A and its role in tumor evolution and intratumoral heterogeneity in pancreatic ductal adenocarcinoma (PDAC). The award will fund this research project over a 3-year period from Sep 30, 2023 to Sep 29, 2026. As...
The University of Texas Health Science Center at Houston received a $2,015,766 Cooperative Agreement from the National Institute on Aging (CFDA 93.866 - Aging Research) to study the impact of circadian rhythm disruptions on the gut-pancreas axis and aging processes. The research aims to determine how changes in food timing and microbiome signaling affect intestinal inflammation and pancreas aging. The project involves both mouse studies and human research to establish the role of microbial...